Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Sep 25 2025

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-sep-25-2025-9

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated September 25, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Paroxetine Extended-Release Tablets USP, 25 mg and 37.5 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases